Abbott Laboratories (ABT) EPS (Basic) (2009 - 2026)

Abbott Laboratories has disclosed EPS (Basic) across 18 years of filings, most recently posting $0.62 for Q1 2026.

• EPS (Basic) for Q1 2026 came in at $0.62, down 18.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.59 (down 53.5% YoY), and the FY2025 annual result was $3.73, down 51.37% from the prior year.
• EPS (Basic) came in at $0.62 for Q1 2026 at Abbott Laboratories, down from $1.01 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $5.28 in Q4 2024 to a low of $0.59 in Q4 2022.
• The 5-year median for EPS (Basic) is $0.82 (2022), against an average of $1.13.
• Across the five-year window, EPS (Basic) jumped 473.91% in 2024 and plunged 80.87% in 2025, its largest moves.
• Abbott Laboratories' EPS (Basic) stood at $0.59 in 2022, then soared by 55.93% to $0.92 in 2023, then surged by 473.91% to $5.28 in 2024, then slumped by 80.87% to $1.01 in 2025, then plunged by 38.61% to $0.62 in 2026.
• The last three EPS (Basic) figures came in at $0.62 (Q1 2026), $1.01 (Q4 2025), and $0.94 (Q3 2025), per Business Quant data.